Medulloblastoma in children: Birmingham experience

Journal of Pediatric Neurosciences

Volumn 1, Issue 2, 2006, Pages 49-55

  Sivasankaran, Anil ^a,b   Sgouros, Spyros ^a   Walsh, Richard ^a   Hockley, Anthony ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b NONE   (Malaysia)

Author keywords

Medulloblastoma; Primitive neuroectodermal tomour

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ATAXIA; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DIPLOPIA; DYSDIADOCHOKINESIA; DYSMETRIA; FOLLOW UP; HUMAN; HYDROCEPHALUS; MEDULLOBLASTOMA; MUTISM; NEUROLOGIC DISEASE; POSTOPERATIVE COMPLICATION; REVIEW; UNITED KINGDOM;

EID: 33748764971     PISSN: 18171745     EISSN: None     Source Type: Journal    
DOI: 10.4103/1817-1745.27453     Document Type: Review

References (33)

1. Vassilyadi M, Farmer JP, Montes JL, Choi S, Blundell JE, Meagher-Villemure K. Medulloblastoma in children. Can J Neurol Sci 1995;22;S34.
2. Geyer R, Levy M, Berger MS, Milstein J, Griffin B, Bleyer WA. Infants with medulloblatoma single institution review of survival. Neurosurgery 1991;29:707-11.
3. Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P. Effects on medulloblastomas resection on outcome in children: A report from the Children Cancer Group. Neurosurgery 1996;38: 265-71.
4. Modha A, Vassilyadi M, George A, Kuehn S, Hsu E, Ventureyra E. Medulloblastoma in children-the Ottawa experience. Childs Nerv Syst 2000;16;341-50.
5. Whelan HT, Krouwer HG, Schmidt MH, Reichert KW, Kovnar EH. Current Therapy and perspectives in the treatment of medulloblastomas. Pediatr Neurol 1998;18:103-15.
6. Cervoni L, Cantore G. Mendulloblastoma in paediatric age: A single institution review of prognostic factocs. Childs Nerv Syst 1995;11: 80-5.
7. Di Rocco C, Ianelli A, Pappaci F, Tamburrini G. Prognosis of medulloblastoma in children. Child Nerv Syst 1997;13;388-96.
8. Evans AE, Jenkin DT, Sposto R ortega JA, Wilson CB, Wara W, et al. The Treatment of medulloblastome: results of a prospective randomised trial of radiation therapy with and without CCNU, Vincrstine and prednisolone. J Neurosurg 1990;72:572-82.
9. Giordana MT, Schiffer P, Schiffer D. Prognostic Fctors in medulloblastoma. Childs Nerv Syst 1998;14:256-62.
10. Packer RJ, Suttan LN, Elterman R, Lange B, Goldwein J, Nicholson HS, et al. Outcome for children with medulloblastoma treateds with radiation and cisplatin, CCNU and vincristine chemotherapy. J Neurosurg 1994;81;690-8.
11. Caputy AJ, McCollough Dc, Mans HJ, Patterson K, Hammock MK. A review of factors influencing the prognosis of medulloblastoma: The importance of cell differentiation. J Neurosurg 1987;66:80-7.
12. Danjoux CE, Jenkin DT, Mclaughlin J, Grimard L, Gasper LE, Dar AR, et al. Childhood medulloblastoma in Ontario,1977-1987; Population based results. Med Pediatr Oncol 1996;26:1-9.
13. Merchant TE, Wong MH, Haida T, Lindsley KL, Finlay J, Dunkel IJ, et al. Medulloblastoma: Long term results for patients treated with definitive radiation therapy during the computed tomograpy era. Int J Radiat Oncol Biol Phys 1996;36;29-35.
14. Halperin EC, Friedman SH. Is there a correlation between duration of presenting symptoms and stage of medulloblastome at the time of diagnosis? Cancer 1996;78:874-80.
15. Belza MG, Donaldson SS, Steinberg GK, Cox RS, Cogen PH. Effects on medulloblastoma: Freedom from relapse longer that 8 years-a therapeutic cure? J Neurosurg 1991;75:575-82.
16. Sure U, Berghorn WJ, Bertlanffy H, Wakabayashi T, Yoshida J, Sugita K, et al. Staging, scoring and grading of medulloblastoma; A postoperative prognosis predicting system based on the cases of a single institute. Acta Neurochir (Wien) 1995;132;59-65.
17. Taomoto K, Tomita T, Raimondi AJ, Leestma JE. Medulloblastoma in childhood: Histological factors influencing patient's outcome. Childs Nerv Syst 1987;3;354-60.
18. Albright AL, Wisoff JH, Zeltzer PM, Deutsch M, Finlay J. Current neurosurgical management of medulloblastomas in children: A report from the Children's Cancer Study Group. Pediatr Neuroci 1989;15:276-82.
19. Rutka HT, Hoffman HJ. A critical review of medulloblastoma: From a difficult past to a promising future. Neurosurg Q 1991;1;54-78.
20. Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, et al. Metastasis stage, adjuvant treatment and residual tumour are prognostic factors for medulloblastomas in children: Conclusion from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999;17;832-45.
21. Agerlin N, Gjerris F, Bricker H, Haase J, Laursen H, Moller KA, et al. Childhood medulloblastoma in Denmark 1960-1984: Population-based retrospective study. Child Nerv Syst 1999;15:29-36.
22. Lee M, Wisoff JH, Abbott R, Freed D, Epstein FJ. Management of hydrocephalus in children with medulloblastoma: Prognostic factors for shunting. Pediatr Neurosurg 1994;20:240-7.
23. Kuhl J. Modern treatment strategies in medulloblastomas. Childs Nerv Syst 1998;14;2-5.
24. Reddy AT, Packer RJ. Pediatric central nervous system tumours. Curr Opin Oncol 1998;10;186-93.
25. Packer RJ. Brain tumours in children. Curr Opin Pediatr 1995;7; 64-72.
26. Brown WD, Tavare CJ, Sobel EL, Gilles FH. Collin's law: A critical review of concept of a period of risk for tumour recurrence and patient survival. Neurosurgery 1995;36:691-7.
27. Olshan JS, Gubernick J, Packer RJ, D'Angio GJ, Goldwein JW, Willi SM, et al. The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 1992:70;2013-7.
28. Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res 1989;25;561-7.
29. Riva D, Pantaleoni C, Milani M, Belani FF. Impairement of neuropsychological function in children with medulloblastoma and astrocytomas in the posterior fossa. Childs Nerv Syst 1989;5;107-10.
30. Chapman CA, Waber DP, Bernstein JH, Pomeroy SL, La Vally B, Sallan SE, et al. Neurobehavioral and neurologic outcome in long term survivors of posterior fossa brain tumours: Role of age and perioperative factors. J Child Neurol 1995;10:209-12.
31. Dennis M, Spiegler BJ, Hetheringto CR, Greenberg M. Neuropsychological sequela of the treatment of children with medulloblastome. J Neuroncol 1996;29:91-100.
32. Packer RJ, Sposto R, Atkins TE, Sutton LN, Bruce DA, Seigel KR, et al. Quality of life in children with PNET of posterior fossa. Pediatr Neurosci 1987;13:169-75.
33. Mulhern RK, Kepner JL, Thomas PR, Armstrong PD, Friedman HS, Kun LE. Neuropsychologic functioning of survivors of childhood medulloblastoma randomised to receive conventional or reduced-dose craniospinal irradiation; A Paediatric Oncology Group study. J Clin Oncol 1998;16:1723-8.